FDA Approves Genzyme’s Cerdelga™ (eliglustat) Capsules Only First-Line Oral Therapy Approved for the Treatment of Adults with Gaucher Disease Type 1 http://news.genzyme.com/press-release/fda-approves-genzymes-cerdelga-eliglustat-capsules